SCHEMBL5633249

SCHEMBL5633249

OC/C=C/C#Cc1ccc(C#C/C=C/CO)cc1

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 5/20 0.35
PPARA Q07869 5/20 0.35
PPARG P37231 2/20 0.35
FFAR1 O14842 2/20 0.31
FFAR4 Q5NUL3 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5633252 1.00 PPARD (0.35) PPARDPPARAPPARGFFAR1FFAR4
SCHEMBL6780291 0.90 FFAR1 (0.39) PPARDPPARAPPARGFFAR1FFAR4
SCHEMBL6780294 0.90 FFAR1 (0.39) PPARDPPARAPPARGFFAR1FFAR4
SCHEMBL5480351 0.89 APP (0.44) PPARDPPARAPPARGFFAR1
SCHEMBL5483934 0.89 APP (0.44) PPARDPPARAPPARGFFAR1
SCHEMBL5480347 0.89 APP (0.44) PPARDPPARAPPARGFFAR1
SCHEMBL7799735 0.85 KIF11 (0.38) FFAR1
SCHEMBL7799739 0.85 KIF11 (0.38) FFAR1
SCHEMBL5634095 0.83 PPARD (0.40) PPARDPPARAPPARGFFAR1FFAR4
SCHEMBL5634092 0.83 PPARD (0.40) PPARDPPARAPPARGFFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7220877-B2 Compounds, their preparation and use NOVO NORDISK A/S (DK) 2007-05-22 US disclosed
EP-1438283-A1 DICARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE NOVO NORDISK A/S (DK) 2004-07-21 EP disclosed
US-20030109579-A1 Novel compounds, their preparation and use HIGH POINT PHARMACEUTICALS, LLC 2003-06-12 US disclosed
WO-2003033453-A1 DICARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THERAPEUTICAL USE NOVO NORDISK A/S (DK) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109579-A1 Novel compounds, their preparation and use PPARG, PPARA, PPARD PPARD 3/4885PPARA 2/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.